Therapeutic impact of 18F-FDG PET/CT in recurrent differentiated thyroid carcinoma

被引：0
|
作者：
Fabio Pomerri
Anna Rita Cervino
Faise Al Bunni
Laura Evangelista
Pier Carlo Muzzio
机构：
[1] Veneto Institute of Oncology IOV-IRCCS,Department of Medicine
[2] Oncologic Radiology Unit,undefined
[3] University of Padua,undefined
[4] Veneto Institute of Oncology IOV-IRCCS,undefined
[5] Radiotherapy and Nuclear Medicine Unit,undefined
来源：
La radiologia medica | 2014年 / 119卷
关键词：
Thyroid carcinoma; Positron emission tomography/computed tomography; Thyroglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 102
页数：5
相关论文
共 50 条
  • [41] 18F-FDG PET/CT must be included in the initial staging of patients with high risk differentiated thyroid carcinoma
    Ucmak, Gulin
    Demirel, Busra
    Akkas, Burcu
    Fidan, Aykut
    Ercakmak, Nur
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [42] The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
    King, A. D.
    Ma, B. B.
    Yau, Y. Y.
    Zee, B.
    Leung, S. F.
    Wong, J. K. T.
    Kam, M. K. M.
    Ahuja, A. T.
    Chan, K. T. C.
    BRITISH JOURNAL OF RADIOLOGY, 2008, 81 (964): : 291 - 298
  • [43] Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
    Mittra, Erik
    El-Maghraby, Tarek
    Rodriguez, Cesar A.
    Quon, Andrew
    McDougall, I. Ross
    Gambhir, Sanjiv S.
    Iagaru, Andrei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (12) : 1952 - 1959
  • [44] Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma
    Albano, D.
    Zizioli, V.
    Odicino, F.
    Giubbini, R.
    Bertagna, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (02): : 87 - 93
  • [45] Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
    Erik Mittra
    Tarek El-Maghraby
    Cesar A. Rodriguez
    Andrew Quon
    I. Ross McDougall
    Sanjiv S. Gambhir
    Andrei Iagaru
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1952 - 1959
  • [46] Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma
    Albano, D.
    Bonacina, M.
    Durmo, R.
    Cerudelli, E.
    Gazzilli, M.
    Dondi, F.
    Mazzoletti, A.
    Bertagna, F.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S218 - S218
  • [47] Role of 18F-FDG PET/CT in detecting recurrent transitional cell carcinoma
    Shamim, S.
    Kaushik, P.
    Hussain, J.
    Arora, G.
    Gupta, S. Datta
    Kumar, R.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S287 - S287
  • [48] The role of 18F-FDG PET/CT testing in the management of a papillary thyroid carcinoma
    Agnieszka Florczak
    Andrea d'Amico
    Thyroid Research, 6 (Suppl 2)
  • [49] What is the impact of 18F-FDG PET/CT in the management of iodine positive metastatic differentiated thyroid cancer.
    Alsalloum, Riyadh
    Tuli, Mahmoud
    Abouzied, Mohei
    Almuhaideb, Ahmad
    Al-Sugair, Abdulaziz
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [50] Contrast-Enhanced 18F-FDG PET/CT in Detection of Recurrent/Metastatic Radioiodine Negative Differentiated Thyroid Carcinomas
    Koranda, P.
    Polzerova, H.
    Quinn, L.
    Buriankova, E.
    Formanek, R.
    Halenka, M.
    Mocnakova, M.
    Kaminek, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S142 - S143
12345